ODQ, NO-sensitive guanylyl cyclase inhibitor
Be the first to review this product! Submit a review
|
(10 Publications)
MW 187.15 Da, Purity >99%. Selective, potent inhibitor of nitric oxide-sensitive guanylyl cyclase. Achieve your results faster with highly validated, pure and trusted compounds.
View Alternative Names
1,8-cineole 2-exo-monooxygenase, AAD20, AI838772, AW493413, Albendazole monooxygenase, Albendazole sulfoxidase, CP33, CP34, CP3A4_HUMAN, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIIA3, CYPIIIA4, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450-PCN1, DKFZp686O15119, DNA-binding factor KBF1, FLJ10358, FLJ11090, GAC, GAM, GLS, GLS1, GLSK_HUMAN, Glucocorticoid inducible P450, Glutaminase C, Glutaminase kidney isoform, Glutaminase phosphate activated, HLP, K-glutaminase, KGA, KIAA0838, L-glutamine amidohydrolase, MGC104252, MGC112732, MGC126680, NF 25, NFKB-p105, Nifedipine oxidase, Nuclear factor NF kappa B, P450 III steroid inducible, P450 PCN1, P450, family III, P450C3, Quinine 3-monooxygenase, RP24-311F12.2, SCAN1, TYDP, TYDP1_HUMAN, Taurochenodeoxycholate 6-alpha-hydroxylase, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, mitochondrial
- Chemical Structure
Lab
Chemical Structure - ODQ, NO-sensitive guanylyl cyclase inhibitor (AB120022)
2D chemical structure image of ab120022, ODQ, NO-sensitive guanylyl cyclase inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Handling instructions
Need more advice on solubility, usage and handling? Please visit our our product support page for more details.
|
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
|
Refer to SDS for further information.
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cytochrome P450 3A4 facilitates the metabolism of endogenous compounds and xenobiotics. It is not part of a stable complex but often works in conjunction with NADPH-cytochrome P450 reductase to carry out its functions. This activity helps in maintaining the balance of hormones and processing compounds for elimination from the body. By metabolizing toxins CYP3A4 protects cells from damage and aids in the detoxification process.
Pathways
The enzyme plays a critical role in the drug metabolism and pharmacokinetics pathways. It interacts with the cytochrome P450 system which includes other enzymes like CYP1A2 and CYP2D6 contributing to the metabolic clearance of drugs. This pathway is essential in determining the half-life of medications within the system and impacts the efficacy and toxicity of therapeutic agents in humans.
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 11:663778 PubMed34235078
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pregnancy 2019:4302309 PubMed31080672
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biomedical reports 9:511-516 PubMed30546879
2018
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 16:1685-1692 PubMed30186388
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurophysiology 111:659-74 PubMed24259545
2013
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 33:15675-85 PubMed24089475
2013
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 33:3390-401 PubMed23426667
2013
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 287:20187-96 PubMed22474320
2012
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 286:33190-202 PubMed21813646
2011
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychopharmacology : official publication of 36:1811-22 PubMed21508928
2011
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com